Biosynthetic gene clusters encode the enzymatic pathways to make secondary metabolites, molecules of great interest for the pharmaceutical and biotechnology industries. Access to an increasing number of microbial genomes, coupled with efficient bioinformatic tools, is creating new momentum in secondary metabolite research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bérdy, J. J. Antibiot. (Tokyo) 58, 1–26 (2005).
Corre, C. & Challis, G.L. Nat. Prod. Rep. 26, 977–986 (2009).
Cimermancic, P. et al. Cell 158, 412–421 (2014).
Weber, T. Int. J. Med. Microbiol. 304, 230–235 (2014).
Ziemert, N. et al. Proc. Natl. Acad. Sci. USA 111, 1130–1139 (2014).
Letzel, A.C. et al. Nat. Prod. Rep. 30, 392–428 (2013).
Rinke, C. et al. Nature 499, 431–437 (2013).
Wilson, M.C. & Piel, J. Chem. Biol. 20, 636–647 (2013).
Umemura, M. et al. PLoS ONE 8, e84028 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Caboche, S. Bioinformatics bolster a renaissance. Nat Chem Biol 10, 798–800 (2014). https://doi.org/10.1038/nchembio.1634
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1634